Empirical Equation For Tunnel Inflow Assessment: Application to a Case History

Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchiv

Strain threshold for ventilator-induced lung injury

Introduction Unphysiological lung strain (tidal volume/functional residual capacity, TV/FRC) may cause ventilator-induced lung injury (VILI) [1]. Whether VILI develops proportionally to the applied strain or only above a critical threshold remains unknown. Methods In 20 healthy, mechanically ventilated pigs, FRC and lung weight were measured by computed tomography. Animals were then ventilated for up to 54 hours with a TV set to produce a predetermined strain. At the end, lung weight was measured with a balance. VILI was defi ned as fi nal lung weight exceeding the initial one. Results Lung weight either did not increase at all (no-VILI group; lung weight change \u201373 \ub1 42 g, n = 9) or markedly augmented (VILI group; 264 \ub1 80 g, n = 11). In the two groups, strain was 1.38 \ub1 0.68 and 2.16 \ub1 0.50 (P <0.01), respectively. VILI occurred only when lung strain reached or exceeded a critical threshold, between 1.5 and 2.1 (Figure 1). Conclusions In animals with healthy lungs VILI only occurs when lung strain exceeds a critical threshold. Reference 1. Gattinoni L, Carlesso E, Cadringher P, et al.: Physical and biological triggers of ventilator-induced lung injury and its prevention [review]. Eur Respir J 2003, 22(Suppl 47):15s-25s

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly. Conventional cellular therapies, such as tumor infiltrating lymphocytes (TIL), are becoming more effective and more available. Gene therapy is becoming an important tool in adoptive cell therapy. Lymphocytes are being engineered to express high affinity T cell receptors (TCRs), chimeric antibody-T cell receptors (CARs) and cytokines. T cell subsets with more naïve and stem cell-like characteristics have been shown in pre-clinical models to be more effective than unselected populations and it is now possible to reprogram T cells and to produce T cells with stem cell characteristics. In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies